Vive Organic, makers of doctor crafted, cold-pressed wellness shots, announced the closing of a $13-million Series B funding round led by Monogram Capital with participation by Cambridge SPG and Powerplant Ventures. Vive is one of the leading functional beverage brands in the market today, providing customers with cold-pressed wellness shots that are formulated with a focus on boosting the immune system. The brand has seen explosive growth since inception in 2015, with an average of 400% growth year over year, and has cemented itself as the leader in this space. This backing from industry veterans further validates the growth opportunity within this category and consumer demand more broadly for immunity-boosting products. Vive will deploy this latest capital raised to expand its digital footprint, foster its innovation pipeline and make its plant-powered products more accessible to consumers nationwide.
Vive Organic was founded in 2015 by CEO Wyatt Taubman, COO Kyle Withycombe and VP of Sales JR Simich, health-conscious friends and entrepreneurs. The brand was inspired by Taubman's personal experience taking a ginger and turmeric shot from a local farmers market to help him overcome a cold during a business trip. The trio recognized there was rising consumer interest in wellness shots and saw an opportunity to develop an industry leading brand designed to support and motivate consumers to proactively boost their immune system. The company works with a team of holistic medicine doctors in its formulation and goes to great lengths to identify the very best ingredients globally, with an emphasis on sourcing some of the purest ginger, turmeric, elderberry and other immunity enhancing ingredients anywhere in the world. Vive leverages cold-pressed technology to extract juice from the roots, herbs and flowers used in their products to provide the freshest product with maximum health benefits. The company’s beverages are organic, non-GMO, gluten free and vegan. Beginning with a focus on the natural channel, Vive has expanded to meet rising demand from customers in 8,000 doors across natural, conventional, mass and drugstore accounts including key banners such as Whole Foods, Sprouts, Safeway, Wegman’s, Target, and CVS.
In February 2020, the brand launched on Amazon and built a direct-to-consumer platform from the ground-up, adding subscription services and extending the brand’s reach to include the entire United States. Over the last several months Vive’s e-commerce sales have increased by 52 times, with production increasing fivefold to allow the brand to keep up with climbing demand at retail. When Taubman set out to raise the Series B, his primary objective was to ensure that Vive could continue to supply its loyal customers during this seminal time in which wellness is their top priority. Armed with a strong balance sheet and investor support network, Vive is well-positioned to capitalize on its vision.